Guidelines Updated for Evaluating, Treating Hirsutism

Share this content:
Guidelines Updated for Evaluating, Treating Hirsutism
Guidelines Updated for Evaluating, Treating Hirsutism

THURSDAY, March 15, 2018 (HealthDay News) -- As an update to an earlier clinical practice guideline, recommendations for evaluating and treating hirsutism in premenopausal women have been issued and published online March 7 in the Journal of Clinical Endocrinology & Metabolism.

Kathryn A. Martin, M.D., from Massachusetts General Hospital in Boston, and colleagues reviewed the literature to update the existing guidelines, published in 2008. The Grading of Recommendations, Assessment, Development, and Evaluation system was used to describe the strength of recommendations and quality of evidence and develop this evidence-based guideline.

The researchers suggest testing all women with an abnormal hirsutism score for elevated androgen levels. Eumenorrheic women with unwanted local hair growth are not recommended to undergo testing for elevated androgen levels. For most women who have patient-important hirsutism despite cosmetic measures, pharmacological therapy is recommended as well as direct hair removal methods for those who want additional cosmetic benefit. Pharmacological therapy or direct hair removal methods are recommended for women with mild hirsutism and no evidence of an endocrine disorder. Oral combined estrogen-progestin contraceptives are the recommended pharmacologic therapy for the majority of women. If the response is suboptimal after six months, adding an antiandrogen is suggested. Unless adequate contraception is used, antiandrogen monotherapy is not recommended. Insulin-lowering drugs are also not recommended. Laser/photoepilation is recommended for most women who choose hair removal therapy.

"Excess facial or body hair is not only distressing to women, it is often a symptom of an underlying medical problem," Martin said in a statement.

One author disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: U.S. Abortion Rate Declined 24 Percent From 2006 to 2015

CDC: U.S. Abortion Rate Declined 24 Percent From ...

Abortions among women ages 15-44 fell 26 percent, from 15.9 to 11.8 abortions per 1,000 women

U of Maryland Student Dies of Adenovirus-Related Illness

U of Maryland Student Dies of Adenovirus-Related Illness

CDC testing of specimen revealed adenovirus type 7, a strain that may cause more severe illness

FDA Approves Drug to Treat Rare Immune Disease

FDA Approves Drug to Treat Rare Immune Disease

Gamifant first drug to be approved specifically for primary hemophagocytic lymphohistiocytosis

is free, fast, and customized just for you!




Already a member?

Sign In Now »